BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25211439)

  • 1. Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status.
    van Santen DK; van der Helm JJ; Grady BP; de Vos AS; Kretzschmar ME; Stolte IG; Prins M
    AIDS; 2014 Nov; 28(17):2589-99. PubMed ID: 25211439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013).
    Klein MB; Rollet-Kurhajec KC; Moodie EE; Yaphe S; Tyndall M; Walmsley S; Gill J; Martel-Laferriere V; Cooper C;
    AIDS; 2014 Aug; 28(13):1957-65. PubMed ID: 25259703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection.
    Hernando V; Perez-Cachafeiro S; Lewden C; Gonzalez J; Segura F; Oteo JA; Rubio R; Dalmau D; Moreno S; Amo JD;
    J Hepatol; 2012 Oct; 57(4):743-51. PubMed ID: 22709620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study.
    Prasad L; Spicher VM; Negro F; Rickenbach M; Zwahlen M;
    J Viral Hepat; 2009 Sep; 16(9):644-9. PubMed ID: 19243494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.
    Walter SR; Thein HH; Amin J; Gidding HF; Ward K; Law MG; George J; Dore GJ
    J Hepatol; 2011 May; 54(5):879-86. PubMed ID: 21145812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of willingness to use direct-acting antiviral-based regimens for hepatitis C virus (HCV) infection among HIV/HCV coinfected people who use drugs.
    Socías ME; Ti L; Dong H; Shoveller J; Kerr T; Montaner J; Milloy MJ
    HIV Med; 2017 Oct; 18(9):647-654. PubMed ID: 28294492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985-2015.
    van Santen DK; van der Helm JJ; Lindenburg K; Schim van der Loeff M; Prins M
    Int J Drug Policy; 2017 Sep; 47():95-101. PubMed ID: 28606392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?
    Rockstroh JK; Peters L; Grint D; Soriano V; Reiss P; Monforte Ad; Beniowski M; Losso MH; Kirk O; Kupfer B; Mocroft A;
    J Hepatol; 2013 Aug; 59(2):213-20. PubMed ID: 23583272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection.
    Scherzer R; Heymsfield SB; Rimland D; Powderly WG; Tien PC; Bacchetti P; Shlipak MG; Grunfeld C;
    AIDS; 2017 Jan; 31(1):71-79. PubMed ID: 27677166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality.
    Klein MB; Rollet KC; Saeed S; Cox J; Potter M; Cohen J; Conway B; Cooper C; Côté P; Gill J; Haase D; Haider S; Hull M; Moodie E; Montaner J; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall M; Walmsley S;
    HIV Med; 2013 Jan; 14(1):10-20. PubMed ID: 22639840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
    Grebely J; Raffa JD; Lai C; Kerr T; Fischer B; Krajden M; Dore GJ; Tyndall MW
    J Viral Hepat; 2011 Jan; 18(1):32-41. PubMed ID: 20196806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption.
    Marcellin P; Pequignot F; Delarocque-Astagneau E; Zarski JP; Ganne N; Hillon P; Antona D; Bovet M; Mechain M; Asselah T; Desenclos JC; Jougla E
    J Hepatol; 2008 Feb; 48(2):200-7. PubMed ID: 18086507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.
    Mena A; Meijide H; Rodríguez-Osorio I; Castro A; Poveda E
    HIV Med; 2017 Oct; 18(9):685-689. PubMed ID: 28230318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is killing people with hepatitis C virus infection?
    Grebely J; Dore GJ
    Semin Liver Dis; 2011 Nov; 31(4):331-9. PubMed ID: 22189973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?
    de Vos AS; van der Helm JJ; Matser A; Prins M; Kretzschmar ME
    Addiction; 2013 Jun; 108(6):1070-81. PubMed ID: 23347124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extreme cause-specific mortality in a cohort of adult prisoners--1988 to 2002: a data-linkage study.
    Kariminia A; Butler T; Corben S; Levy M; Grant L; Kaldor J; Law M
    Int J Epidemiol; 2007 Apr; 36(2):310-6. PubMed ID: 17158524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.
    Matser A; Urbanus A; Geskus R; Kretzschmar M; Xiridou M; Buster M; Coutinho R; Prins M
    Addiction; 2012 Mar; 107(3):614-23. PubMed ID: 21919987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study.
    Duberg AS; Törner A; Davidsdóttir L; Aleman S; Blaxhult A; Svensson A; Hultcrantz R; Bäck E; Ekdahl K
    J Viral Hepat; 2008 Jul; 15(7):538-50. PubMed ID: 18397223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in cause-specific mortality in HIV-hepatitis C coinfection following hepatitis C treatment scale-up.
    Kronfli N; Bhatnagar SR; Hull MW; Moodie EEM; Cox J; Walmsley S; Gill J; Cooper C; Martel-Laferrière V; Pick N; Klein MB;
    AIDS; 2019 May; 33(6):1013-1022. PubMed ID: 30946155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of liver-related death among people who inject drugs in Vancouver, Canada: a 15-year prospective cohort study.
    Hayashi K; Milloy MJ; Wood E; Dong H; Montaner JS; Kerr T
    J Int AIDS Soc; 2014; 17(1):19296. PubMed ID: 25391765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.